scholarly journals Physical activity and bone mineral density in postmenopausal women without estrogen deficiency in menstrual history

2013 ◽  
Vol 3 (3) ◽  
pp. 205-209
Author(s):  
Amila Kapetanović ◽  
Dijana Avdić

Introduction: The estrogen defi ciency after menopause leads to accelerated loss of bone mass. The aim of this study was to examine influence of physical activity on bone mineral density in postmenopausal women who hadn’t a deficit of estrogen in their menstrual history.Methods: This prospective study included 100 postmenopausal women, ages between 50 and 65, living in Sarajevo area without estrogen deficiency in menstrual history. The women in the examination group had osteoporosis. The women in the control group had osteopenia or normal mineral bone density. Mineral bone density was measured at the lumbar spine and proximal femur by Dual–Energy X–ray Absorptiometry using Hologic QDR-4000 scanner. To assess level of physical activity an International Physical Activity Questionnaire - Long Form was used.Results: In the examination group of women who had no history of menstrual estrogen deficit, level of physical activity was low in 52.00% female, and in 48.00% women level of physical activity was moderate. In the control group of women who had no history of menstrual estrogen defi cit in 10.00% female level of physical activity was low, and in 90.00% female level of physical activity was moderate. The difference in levels of physical activity between the two groups was statistically significant, X2 test = 20.6, p <0.005.Conclusion: Results of this study suggest that moderate physical activity has positive impact on bone mineral density in postmenopausal women without estrogen defi ciency in menstrual history and has the potential to reduce rapid bone loss after menopause.

2014 ◽  
Vol 4 (1) ◽  
pp. 26-30
Author(s):  
Amila Kapetanović ◽  
Dijana Avdić

Introduction: Estrogen deficiency leads to bone mass loss and increased risk for osteoporosis. The aim of this study was to examine influence of cigarette smoking on bone mineral density in postmenopausal women with estrogen deficiency in menstrual history.Methods: The total of 100 postmenopausal women living in Sarajevo area, aged 50-65 years, with estrogen deficiency in menstrual history participated in this prospective study. The subjects were divided in two groups, examination and control group, based on bone mineral density values. The women in the examination group had osteoporosis while in the control group were women with osteopenia or normal bone mineral density. Bone mineral density was measured at the lumbar spine and proximal femur by Dual–Energy X–ray Absorptiometry using Hologic QDR-4000 scanner. Smoking habits were assessed for each subject.Results: The average number of cigarettes smoked per day in women with estrogen deficiency in menstrual history was 14.86 in the examination group and 4.67 in the control group. The difference in the average number of cigarettes smoked per day between the two groups was statistically significant (p <0.01). The coefficient of linear correlation between T score and the number of cigarettes smoked per day among women with estrogen deficiency in menstrual history in the examination group was statistically significant (p<0.01). The coefficient of linear correlation between T score and the number of cigarettes smoked per day among women with estrogen deficiency in menstrual history in the control group was statistically significant ( p<0.05).Conclusion: Results of this study suggest that cigarette smoking has negative impact on bone mineral density and that healthy lifestyle (no smoking) has the potential to reduce bone loss in postmenopausal women with estrogen deficiency in menstrual history.


2014 ◽  
Vol 4 (2) ◽  
pp. 105-109 ◽  
Author(s):  
Amila Kapetanović ◽  
Dijana Avdic

Introduction: Complex etiology of osteoporosis include genetic, hormonal, environmental and nutritional factors. The aim of this study was to examine influence of coffee consumption on bone mineral density in postmenopausal women with estrogen deficiency in menstrual history.Methods: This prospective study included 100 postmenopausal women, aged 50-65 years living in Sarajevo area, with estrogen deficiency in their menstrual history. The controlled clinical trials were conducted. Two groups were formed (based on bone mineral density values). The examination group included 50 women who had osteoporosis, while the control group included 50 women without osteoporosis (osteopenia, normal bone mineral density). The lumbar spine and proximal femur bone mineral density was measured by Dual–Energy X–ray Absorptiometry using Hologic QDR-4000 scanner. Coffee drinking habits were assessed for each subject.Results: The average daily intake of coffee in women with estrogen deficiency in menstrual history was at 267.6 ml in the examination group and in the control group 111.6 ml. The difference in the average daily intake of coffee between the two groups was statistically significant (p < 0.001). There was registered significant correlation between intake of coffee and bone mineral density in examination (p < 0.01) and in control group (p < 0.05).Conclusion: This study indicates that coffee consumption is a risk factor for osteoporosis in postmenopausal women, aged 50-65 years living in Sarajevo area, with estrogen deficiency in their menstrual history. It was shown that the effects of coffee on bone mineral density are dose-dependent.


2016 ◽  
Vol 2016 ◽  
pp. 1-6 ◽  
Author(s):  
A. Sánchez ◽  
L. R. Brun ◽  
H. Salerni ◽  
P. R. Costanzo ◽  
D. González ◽  
...  

The aim of this study was to evaluate the effect of denosumab (Dmab) on bone mineral density (BMD) and bone turnover markers after 1 year of treatment. Additionally, the effect of Dmab in bisphosphonate-naïve patients (BP-naïve) compared to patients previously treated with bisphosphonates (BP-prior) was analyzed. This retrospective study included 425 postmenopausal women treated with Dmab for 1 year in clinical practice conditions in specialized centers from Argentina. Participants were also divided according to previous bisphosphonate treatment into BP-naïve and BP-prior. A control group of patients treated with BP not switched to Dmab matched by sex, age, and body mass index was used. Data are expressed as mean ± SEM. After 1 year of treatment with Dmab the bone formation markers total alkaline phosphatase and osteocalcin were significantly decreased (23.36% and 43.97%, resp.), as was the bone resorption marker s-CTX (69.61%). Significant increases in BMD were observed at the lumbar spine, femoral neck, and total hip without differences between BP-naïve and BP-prior. A better BMD response was found in BP-prior group compared with BP treated patients not switched to Dmab.Conclusion. Dmab treatment increased BMD and decreased bone turnover markers in the whole group, with similar response in BP-naïve and BP-prior patients. A better BMD response in BP-prior patients versus BP treated patients not switched to Dmab was observed.


2001 ◽  
Vol 49 (11) ◽  
pp. 1411-1417 ◽  
Author(s):  
James M. Hagberg ◽  
Joseph M. Zmuda ◽  
Steve D. McCole ◽  
Kathleen S. Rodgers ◽  
Robert E. Ferrell ◽  
...  

GYNECOLOGY ◽  
2021 ◽  
Vol 23 (2) ◽  
pp. 173-176
Author(s):  
Il’nur I. Musin ◽  
Timur B. Minasov ◽  
Raisa A. Naftulovich ◽  
Elena M. Popova ◽  
Karina N. Mingareeva ◽  
...  

Background. Plausible predictions of future mortality and disability are useful aids in making decisions about priorities for medical research. Recent advances in medicine have led to the fact that some countries, such as Japan, have the highest life expectancy in the world. Osteoporotic fractures make a significant contribution to the development of morbidity and mortality in the aging population. Despite an active study of the mechanisms of the development of pelvic organ prolapse and disorders of bone mineral density separately, the general background of these diseases has previously been little studied. Aim. To study bone density according to densitometry data in peri- and postmenopausal women. Materials and methods. To carry out this study, 2 groups of women were formed. The first (experimental) group included 76 women admitted for routine surgical treatment of genital prolapse, the second group (control) 68 women without clinical manifestations of pelvic floor descent, who underwent a medical examination by a gynecologist on an outpatient basis. Results. Analysis of extragenital diseases in women included in the study showed a high prevalence in the experimental group of hypertension (p=0.028), osteochondrosis (p=0.001), scoliosis (p=0.028), hemorrhoids (p=0.013). Also, women in this group more often noted stretch marks on the skin (p=0.002) and were more often operated on for other diseases (p=0.043), which indicates the association of genital prolapse with undifferentiated connective tissue dysplasia and hypertension. The diagnosed severe osteoporosis (according to 1 or more densitometry indicators, where the T-score is less than -2.5) had a direct correlation with the duration of menopause. For a detailed analysis of the factors influencing severe osteoporosis in peri- and postmenopausal women, logistic regression analysis and ROC analysis were performed. The independent variable was the presence of severe osteoporosis, and the dependent variables were: stage according to POP-Q, the presence of hypertension, the presence of diabetes mellitus in history. Conclusion. This study confirms the presence of a comorbidity decrease in bone density according to densitometry and the presence of hypertension (p=0.028) and genital prolapse. According to the ROC analysis, an increase in the stage of genital prolapse according to the POP-Q classification increases the risk of developing severe osteoporosis.


Menopause ◽  
2019 ◽  
Vol 26 (11) ◽  
pp. 1284-1288
Author(s):  
Lijuan Yang ◽  
Xiang Hu ◽  
Hailing Zhang ◽  
Wei Pan ◽  
Weihui Yu ◽  
...  

Maturitas ◽  
2011 ◽  
Vol 70 (1) ◽  
pp. 80-84 ◽  
Author(s):  
Kaori Kitamura ◽  
Kazutoshi Nakamura ◽  
Ryosaku Kobayashi ◽  
Rieko Oshiki ◽  
Toshiko Saito ◽  
...  

2017 ◽  
Vol 26 (5) ◽  
pp. 461-466 ◽  
Author(s):  
Jing Xiang ◽  
Yongjie Chen ◽  
Yupeng Wang ◽  
Shaofei Su ◽  
Xinyu Wang ◽  
...  

2013 ◽  
Vol 66 (suppl. 1) ◽  
pp. 67-71
Author(s):  
Ivana Bozic ◽  
Svetozar Damjanovic ◽  
Djuro Macut ◽  
Violeta Mihailovic-Vucinic

Introduction. Sarcoidosis is a chronic, multi-organ, inflammatory disease which predominantly affects the lungs. Although direct osseous involvement in sarcoidosis is rare, patients with this disease, regardless of the presence of osseous lesions, are at a great risk of developing osteoporosis. Osteoporosis is a consequence of the disease itself, as well as of its treatment. Osteodensitometry. Osteodensitometry is the gold standard for osteoporosis diagnosis, and it is based on the assessment of the bone mineral density. One of the main drawbacks of osteodensitometry as a method for osteoporosis verification is its inability to determine bone micro-architectonics, which is a significant element of bone strength. Mineral Bone Density in Patients with Sarcoidosis. It has been shown that newly diagnosed, yet untreated patients with sarcoidosis have rapid bone remodeling, although their mineral bone density is normal or low to normal. This suggests that the low bone strength in patients with sarcoidosis is a consequence of mechanisms that predominantly disturb the bone micro-architectonics, but they do not have a significant effect on the bone mineral density at the same time. Vertebral Fractures and their Diagnosis in Patients with Sarcoidosis. Normal bone mineral density in patients with sarcoidosis does not preclude skeletal fractures, primarily vertebral fractures. Osteodensitometry devices allow a relatively easy detection of vertebral fractures in patients with sarcoidosis. Conclusion. Osteodensitometry is recommended in every patient with sarcoidosis initially as well as during the follow up and treatment. Even if osteodensitometry is normal, the possibility of vertebral fractures should not be overlooked in these patients.


Sign in / Sign up

Export Citation Format

Share Document